NALINI PACKIANATHAN: Open Payments
NPI 1750653101 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,747 in 54 payments from 15 companies in 2025. Trend: 2023 $81 · 2024 $270 · 2025 $1,747
Food & beverage: $1,673Education: $74
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 15 | $419 |
| GENZYME CORPORATION | 9 | $349 |
| PFIZER INC. | 9 | $271 |
| AstraZeneca Pharmaceuticals LP | 3 | $252 |
| GlaxoSmithKline, LLC. | 2 | $143 |
| Novartis Pharmaceuticals Corporation | 5 | $94 |
| BioCryst US Sales Co., LLC | 2 | $40 |
| Galderma Laboratories, L.P. | 2 | $39 |
| Sequel Med Tech, LLC | 1 | $28 |
| UCB, Inc. | 1 | $22 |
Products named: DUPIXENT, CIBINQO, AIRSUPRA, LITFULO, NUCALA, FASENRA, ORLADEYO, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
